KURT ATKIN: Open Payments
NPI 1770646663 · MCMINNVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 64 payments from 29 companies in 2025. Trend: 2023 $1,647 · 2024 $1,681 · 2025 $1,404
Food & beverage: $1,304Education: $100
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 22 | $184 |
| AstraZeneca Pharmaceuticals LP | 7 | $178 |
| Janssen Biotech, Inc. | 2 | $134 |
| SEAGEN INC. | 1 | $100 |
| Astellas Pharma US Inc | 3 | $95 |
| GENZYME CORPORATION | 3 | $78 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Exelixis Inc. | 2 | $51 |
| Agios Pharmaceuticals, Inc. | 1 | $40 |
| Tempus AI, Inc | 1 | $29 |
Products named: PADCEV, RYBREVANT, SARCLISA, KEYTRUDA, ENHERTU, CABOMETYX, PYRUKYND, LYNPARZA.
Industry payments across OR — which companies pay providers there.
